GE Audio & Video: Podcasts, Stream GE, On Demand
skip to main contentskip to secondary navigationClick on any phrase to jump to that point in the video.
[[New Look at Cancer: a partnership between GE & Lilly]]
[[Dr. Richard Gaynor V.P. Cancer Research and Clinical Investigation Lilly Research Laboratories]]
[I'm Richard Gaynor, I'm Vice-President of Cancer Research]
[and Global Product Development in Oncology ]
[In the past, when you look at biomarkers, you can ]
[look at usually one biomarker in a cancer cell.]
[In the old days, you couldn't even look at one]
[biomarker you just looked at histology as the architecture--]
[For the first time, we can really visualize networks, which are]
[communications in cells of cancer cells.]
[Cancer is a very prevalent illness.]
[About one in three people will get cancer.]
[So if you look at people walking around,]
[and in addition, someone in their family would have it. ]
[What this technology allows us to do is to understand the ]
[signature of these different cancers]
[so we can treat them better. ]
[We're going to be able to individualize therapy now based]
[on this breakthrough and that's very, very exciting. ]
[What GE and Lilly have been able to do ]
[is now look at 25 biomarkers,]
[25 proteins within a single cell,]
[and get a real picture of the health of that cell--]
[a health of the cell, a health of the whole environment]
[What this does is really tell us how the cell]
[is living, how the cell is breathing,]
[and what's wrong with the cell. ]
[And what we found is between different cancers, ]
[there's differences in these networks.]
[Not all cancers are the same. ]
[And it's an important thing to]
[be able to provide new tools to ]
[doctors and to patients so they can ]
[live with their cancer and potentially be cured of their cancer. ]
[It'll really be helpful in getting the right drug]
